Archive for the ‘research’ Category

New UVA Study Tentatively Links Ticks to Heart Disease

https://news.virginia.edu/content/new-uva-study-tentatively-links-ticks-heart-disease?utm_source=DailyReport&utm_medium=email&utm_campaign=news

NEW UVA STUDY TENTATIVELY LINKS TICKS TO HEART DISEASE

The bite of the lone star tick had previously been shown to cause an allergy to red meat. Now it is linked with an increased risk of heart disease.

June 14, 2018 Josh Barney, jdb9a@virginia.edu

University of Virginia School of Medicine researchers have linked sensitivity to an allergen in red meat – a sensitivity spread by tick bites – with a buildup of fatty plaque in the arteries of the heart. This buildup may increase the risk of heart attacks and stroke.

The bite of the lone star tick can cause people to develop an allergic reaction to red meat. However, many people who do not exhibit symptoms of the allergy are still sensitive to the allergen found in meat. UVA’s new study linked sensitivity to the allergen with the increased plaque buildup, as measured by a blood test.

The researchers emphasize that their findings are preliminary, but say further research is warranted.

tick_story_da_inline_01
The research team drew from both allergists and cardiologists, and included, from left, Dr. Thomas Platts-Mills, Dr. Coleen McNamara, Dr. Jeff Wilson and Anh Nguyen. (Photo by Dan Addison, University Communications)

“This novel finding from a small group of subjects examined at the University of Virginia raises the intriguing possibility that asymptomatic allergy to red meat may be an under-recognized factor in heart disease,” said study leader Dr. Coleen McNamara of UVA’s Robert M. Berne Cardiovascular Research Center and UVA’s Division of Cardiovascular Medicine. “These preliminary findings underscore the need for further clinical studies in larger populations from diverse geographic regions.”

Allergens and Clogged Arteries

Looking at 118 patients, the researchers determined that those sensitive to the meat allergen had 30 percent more plaque accumulation inside their arteries than those without the sensitivity. Further, a higher percentage of the plaques had features characteristic of unstable plaques that are more likely to cause heart attacks.

With the meat allergy, people become sensitized to alpha-gal, a type of sugar found in red meat. People with the symptomatic form of the allergy can develop hives, stomach upset, have trouble breathing or exhibit other symptoms three to eight hours after consuming meat from mammals. (Poultry and fish do not trigger a reaction.)

What’s it like to develop a meat allergy?   https://makingofmedicine.virginia.edu/2018/03/29/the-meat-allergy-whats-it-like/

Other people can be sensitive to alpha-gal and not develop symptoms. In fact, far more people are thought to be in this latter group. For example, up to 20 percent of people in Central Virginia and other parts of the Southeast may be sensitized to alpha-gal, but not show symptoms.

The allergy to alpha-gal was first reported in 2009 by Dr. Thomas Platts-Mills, who heads UVA’s Division of Allergy and Clinical Immunology, and his colleague Dr. Scott Commins. Since then, there have been increasing numbers of cases of the meat allergy reported across the U.S., especially as the lone star tick’s territory grows. Previously found predominantly in the Southeast, the tick has now spread west and north, all the way into Canada.

UVA’s new study suggests that doctors could develop a blood test to benefit people sensitive to the allergen.

“This work raises the possibility that in the future a blood test could help predict individuals, even those without symptoms of red meat allergy, who might benefit from avoiding red meat. However, at the moment, red meat avoidance is only indicated for those with allergic symptoms,” said researcher Dr. Jeff Wilson of UVA’s allergy division.

Findings Published

The work represents a significant collaboration between allergy and cardiology experts at UVA. The researchers have published their findings in Arteriosclerosis, Thrombosis and Vascular Biology, a journal of the American Heart Association. The research team consisted of Wilson, Anh Nguyen, Alexander Schuyler, Commins, Angela Taylor, Platts-Mills and McNamara.

The work was supported by the National Institutes of Health, grants KO8-AI085190, K23-HL093118, RO1-AI 20565, PO1-HL55798, RO1-HL136098-01 and RO1-HL107490.

MEDIA CONTACT

Josh Barney
UVA Health System
jdb9a@virginia.edu 434-243-1988

________________

For more:  https://madisonarealymesupportgroup.com/2018/05/04/arkansas-woman-develops-deadly-meat-allergy-after-tick-bite/

https://madisonarealymesupportgroup.com/2017/01/12/tick-related-red-meat-allergy-found-in-minnesota-wisconsin/

https://madisonarealymesupportgroup.com/2018/06/27/alpha-gal-perioperative-management/

https://madisonarealymesupportgroup.com/2018/01/16/a-strange-itch-trouble-breathing-then-anaphylactic-shock/

 

Surveillance For Heartland & Bourbon Viruses in Eastern Kansas

https://academic.oup.com/jme/advance-article/doi/10.1093/jme/tjy103/5045816

Surveillance for Heartland and Bourbon Viruses in Eastern Kansas, June 2016

Savage HM, Godsey MS Jr, Tatman J, Burkhalter KL, Hamm A, Panella NA, Ghosh A, Raghavan RK.
Journal of Medical Entomology, online first 2018 Jun 27.

Abstract

In June 2016, we continued surveillance for tick-borne viruses in eastern Kansas following upon a larger surveillance program initiated in 2015 in response to a fatal human case of Bourbon virus (BRBV) (Family
Orthomyxoviridae: Genus Thogotovirus). In 4 d, we collected 14,193 ticks representing four species from four sites.

Amblyomma americanum (L.) (Acari: Ixodidae) accounted for nearly all ticks collected (n = 14,116, 99.5%), and the only other species identified were Amblyomma maculatum Koch (Acari: Ixodidae),
Dermacentor variables (Say) (Acari: Ixodidae) and Ixodes scapulars Say (Acari: Ixodidae). All ticks were tested for both BRBV and Heartland virus (Family Bunyaviridae: Genus Phlebovirus) in 964 pools.

Five Heartland virus positive tick pools were detected and confirmed by real-time reverse transcription PCR (rRT-PCR), while all pools tested negative for BRBV. Each Heartland positive pool was composed of 25 A. americium nymphs with positive pools collected at three different sites in Bourbon County.

A. americanum is believed to be the primary vector of both Heartland and BRBVs to humans based upon multiple detections of virus in field-collected ticks, its abundance, and its aggressive feeding behavior on mammals including humans. However, it is possible that A. americium encounters viremic vertebrate hosts of BRBV less frequently than viremic hosts of Heartland virus, or that BRBV is less efficiently
passed among ticks by co-feeding, or less efficiently passed vertically from infected female ticks to their offspring resulting in lower field infection rates.

_____________

For more:  https://madisonarealymesupportgroup.com/2017/07/01/one-tick-bite-could-put-you-at-risk-for-at-least-6-different-diseases/ (Actually it’s 18 and counting)

Lyme Periprosthetic Joint Infection in Total Knee Arthroplasty

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994602/#__ffn_sectitle

Lyme periprosthetic joint infection in total knee arthroplasty

Murillo Adrados, MD,a,∗ Daniel Howard Wiznia, MD,a Marjorie Golden, MD,b and Richard Pelker, MD, PhDa

Abstract
Lyme arthritis, caused by the spirochete Borrelia burgdorferi sensu stricto, is a common tick-borne illness in New England and the upper Midwest. Most often, the disease affects the knee and has typically been reported as a cause of native joint infection. There has been only 1 case of Lyme periprosthetic joint infection (associated with a total knee arthroplasty) reported in the literature, and to our knowledge, no other reported cases of Lyme periprosthetic joint infections exist. In this article, we report on 2 patients diagnosed with prosthetic joint infections who were subsequently found to have Lyme prosthetic joint infections, with B burgdorferi as the infectious organism. We discuss the medical and surgical management of these patients.

________________

**Comment**

Trust me – there’s more out here with this particular issue in Lyme-land but the medical field is in denial, testing is horrific, and doctors are hell-bent on diagnosing patients with everything BUT Lyme and Co.

Here’s another study explaining that periprosthetic joint infection, “is one of the most devastating and costly complications following total joint arthroplasty (TJA). Diagnosis and management of PJI is challenging for surgeons. There is no “gold standard” for diagnosis of PJI, making distinction between septic and aseptic failures difficult. Additionally, some of the greatest difficulties and controversies involve choosing the optimal method to treat the infected joint.”  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601222/.

It’s when bacteria adhere to the knee implant.  In this case, it’s the Lyme bacteria, Bb.

This, BTW, is happening in every single organ of the human body, it’s just the science hasn’t caught up to the pathogen.

 

 

Lyme Disease Presenting With Multiple Cranial Neuropathies on MRI

Lyme disease presenting with multiple cranial neuropathies on MRI

Piché-Renaud PP, Branson H, Yeh EA, Morris SK.
IDCases. 2018 Apr 11;12:117-118. eCollection 2018.

https://doi.org/10.1016/j.idcr.2018.04.004

Abstract

We present the case of a 10-year old patient from southeastern Ontario with severe bilateral facial palsy. MRI was performed that showed extensive symmetric enhancement of cervical cranial nerve roots and multiple cranial nerves (III, V, VI, VII, VIII, X and XII).

Lumbar puncture was performed that revealed pleocytosis and elevated proteins in the cerebrospinal fluid. Serology confirmed the diagnosis of neuroborreliosis. The patient was treated with a 4-week course of IV ceftriaxone, following which he returned to baseline.

________________

**Comment**

This case is a perfect example of the importance understanding the organism and of the need for follow up.  The case study follows the idea that borrelia can be eradicated quickly and easily which is just not to case for many patients.

It is my strong opinion that people once infected with Lyme/MSIDS should be checked yearly if not more frequently for symptoms.  Once Bb is in the central nervous system, it can proliferate anywhere.  Follow up would show most probably show symptoms that come and go that are directly related to infection.  People treated like this often fall through the cracks and physicians do not connect later symptoms with previous infection.

For an example of how a successful doctor, also a founding member of the IDSA,  treated Lyme/MSIDS cases right here in Wisconsin: https://madisonarealymesupportgroup.com/2017/07/09/idsa-founder-used-potent-iv-antibiotics-for-chronic-lyme/

“….two protocols to be considered for the treatment of chronic LD that includes 6-8 grams of IV ceftriazone for at least 6 weeks and longer if the syndrome has entrenched itself for over a year or if the response is coming along slowly. In tandem with the IV antibiotics he typically also used doxycycline, an erythromycin, Diflucan, Flagyl, Valtrex, and gamma globulin. When there was not a satisfactory clinical response he would treat Babesia with Mepron and/or other antimalarials. For evidence of intransigent bartonellosis (Bell’s palsy of the face and gut, and chronic dermatitis) he would add rifampin and sometimes intravenous genamicin.  That’s a far cry more than the CDC/IDSA mono treatment mandate of doxycycline.

Notice the overlapping treatment?  This is how most knowledgable practitioners treat this complex illness which automatically takes into account the probably of other pathogens besides Bb.

For more treatment options:  https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/

More cases of cranial neuropathy:  https://madisonarealymesupportgroup.com/2017/06/01/cns-lyme-disease-with-cranial-neuropathies-and-mimicking-b-cell-lymphoma/

https://madisonarealymesupportgroup.com/2018/02/07/cranial-neuropathy-severe-pain-due-to-bb-infection/

Cognitive Decline in Post-Treatment Lyme Disease Syndrome

https://doi.org/10.1093/arclin/acy051https://doi.org/10.1093/arclin/acy051

Abstract

*Objective*
Patient-reported cognitive complaints are common in those with
post-treatment Lyme disease syndrome (PTLDS). Objective evidence of
cognitive impairment in this population is variable in part due to
methodological variability in existing studies. In this study, we sought
to use a systematic approach to characterizing PTLDS based on the most
current consensus diagnosis. We further examined PTLDS-related cognitive
decline, operationalized as a significant decline in cognitive test
performance relative to premorbid cognitive ability.

*Method*
We enrolled a case series of 124 patients with confirmed PTLDS defined
by Infectious Diseases Society of America-proposed case definition.
Cognitive functioning was evaluated using standardized
neuropsychological measures.

*Results*
The majority (92%) of participants endorsed some level of cognitive
difficulty, yet 50% of the sample showed no statistically or clinically
significant cognitive decline, 26% of the sample evidenced significant
cognitive decline on measures of memory and variably on measures of
processing speed, and 24% of the sample were excluded from analyses due
to suboptimal test engagement.

*Conclusions*
The current findings are consistent with the literature showing that the
most robust neurocognitive deficit associated with PTLDS is in verbal
memory and with variable decline in processing speed. Compared to
population normative comparison standards, PTLDS-related cognitive
decline remains mild. Thus, further research is needed to better
understand factors related to the magnitude of subjective cognitive
complaints as well as objective evidence of mild cognitive decline.

________________

**Comment**

Please know the first challenge is the limitation of a PTLDS definition by the IDSA – those that believe Lyme is little more than “aches and pains” of daily living and who follow the unscientific and antiquated CDC Lyme guidelines.

Second – there is vast disagreement in the Lyme world about PTLDS.  There are hundreds of studies showing persistent infection, yet The CDC/IDSA do not believe in the possibility of persistent infection – just immune “blow back,” or the infamous PTLDS.   While there certainly are immune issues with Lyme/MSIDS, please watch Dr. Cameron’s video on it for a different take: https://madisonarealymesupportgroup.com/2018/03/15/lyme-hangout-with-dr-cameron-ptlds/

Third – and this is important, Lyme/MSIDS symptoms are notoriously intermittent, which means you can be bed-bound one day and walking the next.  You can have severe brain fog and memory loss one day and not another.  This is hallmark.  Lyme/MSIDS patients go to the ER frequently with severe, frightening symptoms, yet are commonly sent home and told the tests are all “normal,” so the fact that “50% of the sample showed no statistically or clinically significant cognitive decline,” does not shock me.  This sort of test probably needs to be given over a period of time to show anything at all.  If you study the organism in any relevant depth, this idea that we are going to give these patients a singular test and expect to see statistically significant things is really pretty silly if you think about it.

Until the obvious flaws are dealt with, this study joints hundreds of others that are used to justify the lack of concern about very chronically ill people with Lyme/MSIDS.  This article reveals it superbly:  https://madisonarealymesupportgroup.com/2018/06/28/the-science-isnt-settled-on-chronic-lyme/

Lyme Advocate Carl Tuttle says this about the study:

Your study like so many others over the past three decades avoids this class of debilitated patient who missed early treatment and became disabled. Your study results are then assumed to apply to the entire patient population giving the impression that Lyme is no big deal…just some “mild cognitive decline.”

This is a continuation of the racketeering scheme identified in the SHRADER & ASSOCIATES, LLP RICO lawsuit where the ongoing disinformation campaign is aimed at promoting the idea that Lyme is little more than a nuisance disease (Aches and pains of daily living)

Lyme disease has been misclassified as a low-risk and non-urgent health issue as there are no Public Service Announcements informing the public that you could become horribly disabled or die from Lyme disease.

https://www.change.org/p/1120418/u/22944699?utm_medium=email&utm_source=petition_update&utm_campaign=366556&sfmc